Stocktoria
Estrella Immunopharma, Inc. ESLA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-19
Estrella Immunopharma, Inc. statistics & valuation
Market cap$42.3M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Return on assets | -411.2% | -164.2% | -367.0% | -10.2% | — |
| Return on equity | 126.0% | -171.1% | 94.7% | 15.4% | — |
| Current ratio | 0.12 | 24.65 | 0.28 | 0.05 | 0.83 |
Source: SEC EDGAR filings · CIK 0001844417 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.